Authors
Sarah C J Jorgensen, David L McClure
Published in
The Journal of clinical endocrinology and metabolism. Nov 10, 2026. Epub Nov 10, 2026.
Abstract
Testosterone use among females has risen recently, partly fueled by consumer-directed marketing for a wide range of unsupported indications. Hypoactive sexual desire disorder (HSDD) in postmenopausal females remains the only evidence-based indication.
To describe characteristics of females initiating testosterone, indications, temporal trends, serum concentration monitoring, and duration of therapy.
Retrospective new-user cohort study using TriNetX de-identified electronic health record (EHR) data. Adult females newly prescribed testosterone 2016-2024 were included. Patients with gender incongruence were excluded.
In total, 10,185 females were included; median age 52 (42-59) years. Cardiac disease, ≥1 psychiatric diagnosis, and a history of breast or gynecological cancer were documented in 20%, 36%, 3.1% and 2.8%, respectively. HSDD was documented in 17%. The annual percent change in new testosterone users was 7.5% (95% CI, -1.0-10%) 2016-2022 and 22% (95% CI, 12-29%) 2022-2024. The prevalence of testosterone serum concentration monitoring was 16% at baseline and 10% at 60-180 days. Concentrations >70ng/dL were documented in 38% of those tested at follow-up. 59% received a single testosterone prescription; among those with ≥2 prescriptions, the median time to discontinuation was 19.3 months (95% CI, 18.8-20.0).
New testosterone use among females increased over the study, was most often prescribed without a documented HSDD diagnosis, many had pre-existing conditions excluded from clinical trials, monitoring reported in the EHR was low, and concentrations >70 ng/dL were documented in 38% of those tested. Among those who continued therapy, a substantial proportion persisted beyond 24 months for which limited safety data are available.
PMID:
43006835
Bibliographic data and abstract were imported from PubMed on 10 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 12
- Comments 0